14th Annual Pfizer Frontiers in Human Disease Symposium
The Role of Cilia in Biology and Medicine
May 4th & 5th 2022
The Pfizer Frontiers in Human Disease Symposium aims to address rapidly emerging areas of biomedical science and technology that will influence future development of novel therapeutics. This year’s topic,“The Role of Cilia in Biology and Medicine,” will be presented by widely recognized thought leaders who perform highly impactful research in the topic area.
Agenda
- Wednesday, May 4th
9:15 a.m. – 9:30 a.m. ET Log in 9:30 a.m. – 9:45 a.m. ET Welcome – Morris J. Birnbaum, MD, PhD
Pfizer
Senior Vice President, Internal Medicine Research UnitOpening Remarks – Peter Jackson, PhD
Stanford University School of Medicine
Professor of Microbiology and Immunology and of Pathology
Session 19:45 a.m. – 10:30 a.m. ET Lukas Sommer, PhD
University of Zurich
Professor, Medical Faculty and Faculty of Science
“ The Role of Cilia in Tumorigenesis” | Abstract10:30 a.m. – 11:15 a.m. Jing Hughes, MD, PhD
Washington University School of Medicine in St. Louis
Associate Professor of Medicine, Division of Endocrinology, Metabolism & Lipid Research
“Primary cilia in pancreatic islet function” | Abstract11:15 a.m. – 11:30 a.m. ET Break 11:30 a.m. – 12:15 a.m. ET Gaia Pigino, PhD
Human Technopole
Associate Head of Structural Biology Research Center
“Structural cell biology of cilia and intraflagellar transport” | Abstract12:15 a.m. – 1:00 p.m. ET Breakout Session: Group Networking/Office Hours with Session 1 speakers 1:00 p.m. – 2:00 p.m. ET Lunch
Session 22:00 p.m. – 2:45 p.m. ET Rajat Rohatgi, MD, PhD
Stanford University School of Medicine
Associate Professor of Biochemistry and of Medicine (Oncology)
“ Cholesterol accessibility at the ciliary membrane regulates Hedgehog signaling” | Abstract2:45 p.m. – 3:30 p.m. ET Ken-Ichi Takemaru, PhD
Stony Brook University
Professor, Department of Pharmacological Sciences
“Chibby Family Members and Their Regulators in Ciliogenesis and Ciliopathies” | Abstract3:30 p.m. – 3:35 p.m. ET Closing Remarks – Morris J. Birnbaum, M.D., Ph.D.
Pfizer, SVP-Chief Scientific Officer, Internal Medicine Research Unit3:35 p.m. - 4:20 p.m. ET Breakout Session: Group Networking/Office Hours with Session 2 speakers 4:20 p.m. ET End of Day 1 - Thursday, May 5th
9:15 a.m. – 9:30 a.m. Log in 9:30 a.m. – 9:45 a.m. Welcome – Morris J. Birnbaum, MD, PhD
Pfizer
Senior Vice President, Internal Medicine Research UnitOpening Remarks – Mikael Dolsten, MD, PhD
Pfizer
Chief Scientific Officer, President, Worldwide Research, Development and MedicalSession 3
9:45 a.m. – 10:30 a.m Pleasantine Mill, PhD
University of Edinburgh
Group Leader, MRC Human Genetics Unit, Institute of Genetics and Cancer
“Cilia in Development and Disease: Dynamics, Diversity and Reversing Disease Phenotypes” | Abstract10:30 a.m. – 11:15 a.m. Bradley Yoder, PhD
University of Alabama
Professor / Chairperson, Cell, Developmental, and Integrative Biology
“Cilia, injury, and cystic kidney diseases” | Abstract11:15 a.m. – 11:30 a.m. Break 11:30 a.m. – 12:15 a.m. Cecilia Lo, PhD
University of Pittsburgh
Distinguished Professor and F. Sargent Cheever Chair, Department of Developmental Biology
“Cilia in the complex genetics of congenital heart disease” | Abstract12:15 a.m. – 1:00 a.m. Breakout Session: Group Networking/Office Hours with Session 3 speakers 1:00 p.m. – 2:00 p.m. Lunch Session 4
2:00pm-2:45pm ET David Clapham, MD, PhD
Howard Hughes Medical Institute
Janelia Group Leader
“A serotonergic axon-cilium synapse drives nuclear signaling in the brain” | Abstract2:45pm-3:30pm ET Peter Jackson, PhD
Stanford University School of Medicine
Professor of Microbiology and Immunology (Baxter Labs) and of Pathology
“Ciliary Control of Metabolic Signaling” | Abstract3:30pm-3:35pm ET Closing Remarks - Morris J. Birnbaum, MD, PhD
Pfizer, SVP-Chief Scientific Officer, Internal Medicine Research Unit3:35pm-4:20pm ET Breakout Session: Group Networking/Office Hours with Session 4 speakers 4:20 ET End of Symposium
Hosts
CO-ORGAINIZER, Senior Vice President, Internal Medicine Research Unit, Pfizer
SPONSOR, Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer Inc.
CO-ORGAINIZER, Professor of Microbiology and Immunology (Baxter Labs) and of Pathology, Stanford University School of Medicine
CO-ORGAINIZER, Senior Vice President, Internal Medicine Research Unit, Pfizer
SPONSOR, Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer Inc.
CO-ORGAINIZER, Professor of Microbiology and Immunology (Baxter Labs) and of Pathology, Stanford University School of Medicine
CO-ORGAINIZER, Senior Vice President, Internal Medicine Research Unit, Pfizer
SPONSOR, Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer Inc.
CO-ORGAINIZER, Professor of Microbiology and Immunology (Baxter Labs) and of Pathology, Stanford University School of Medicine
CO-ORGAINIZER, Senior Vice President, Internal Medicine Research Unit, Pfizer
SPONSOR, Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer Inc.
CO-ORGAINIZER, Professor of Microbiology and Immunology (Baxter Labs) and of Pathology, Stanford University School of Medicine
